abrdn Life Sciences Investors (NYSE:HQL)
$ 13.05 -0.17 (-1.29%) Market Cap: 356.92 Mil Enterprise Value: 356.92 Mil PE Ratio: 16.52 PB Ratio: 0.87 GF Score: 43/100

abrdn Life Sciences Investors (HQL) Transcripts

    • 1